Weight-loss drug concept stocks including Hanyu Pharmaceutical, Huadong Pharmaceutical, Asymex, Amic, etc. rose sharply yesterday.

Morgan Stanley estimates based on market demand that the market size of weight loss drugs is expected to exceed US$54 billion by 2030. The world's most popular GLP-1 drugs come from Denmark's Novo Nordisk and the United States' Eli Lilly and Company. The two companies are spending heavily to increase the production capacity of related drugs.